Immunization News and Research

RSS

Effective vaccine strategies for New South Wales Australia under different vaccine supply

Researchers say mass immunization will terminate the disease, or immunizing 66% of the population with a 90% efficacy vaccine will achieve herd immunity.

21 Dec 2020

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

As the coronavirus disease 2019 (COVID-19) pandemic continues to intensify in many parts of the world, vaccine development is proceeding apace.

21 Dec 2020

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States.

18 Dec 2020

Study shows highest risk of vitamin D deficiency in BAME babies

A third of all babies and half of Black, Asian and Minority Ethnic (BAME) babies are vitamin D deficient, a large study of 3000 newborn's in the West Midlands has shown, highlighting potential shortfalls in the current UK antenatal supplementation program.

16 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

The effect of vaccination on the spread of COVID-19 disease

Researchers from Cornell University, USA, have modeled the effect of vaccination on the spread of COVID-19 disease. They suggest that vaccinating healthcare workers first followed by people who have many social interactions, such as grocers and airline cabin crew, will help reduce transmission. The research is published on the preprint server medRxiv*, prior to peer review.

14 Dec 2020

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

The onslaught of the COVID-19 pandemic, the hunt for a drug, and the successful development of a vaccine has impacted people beyond measure worldwide.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

New polio vaccine is the first to work on mutated form of the virus

A new polio vaccine that could tackle mutated strains of the disease has passed phase II clinical trials, according to two studies published in medical journal The Lancet.

10 Dec 2020

$20.6 billion to restore crumbling services for women, newborns, children and adolescents

The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.

10 Dec 2020

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

UCI researchers develop new technology to rapidly hypermutate antibodies

Using the same strain of yeast that ferments wine and makes dough rise, a team led by University of California, Irvine and Harvard Medical School researchers has developed an in vitro technology that can rapidly hypermutate antibodies.

8 Dec 2020

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Researchers at the School of Medicine, Washington University in Saint Louis, USA, showed that the intranasal route of immunization could provide a more efficient protection against SARS-CoV-2 compared to the intramuscular route (i.e. through ‘jabs’).

7 Dec 2020

Researchers urge policymakers to prioritize people with diabetes for COVID-19 vaccination

Vanderbilt University Medical Center researchers have discovered individuals with type 1 and type 2 diabetes infected with COVID-19 are three times more likely to have a severe illness or require hospitalization compared with people without diabetes.

5 Dec 2020

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

St Petersburg University scientists have analyzed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world.

3 Dec 2020

Come for your eye exam, leave with a band-aid on your arm

With multiple COVID-19 vaccines rapidly heading toward approval, optometrists and dentists are pushing for the authority to immunize patients during routine eye exams and dental cleanings.

3 Dec 2020

Feds look to pharmacists to boost childhood immunization rates

Torey Watson is trained as a pharmacist but aims to do more than simply fill prescriptions.

3 Dec 2020

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USAsm, part of a global project to increase understanding of factors that influence people's willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy.

3 Dec 2020

Immunization News and Research

Effective vaccine strategies for New South Wales Australia under different vaccine supply

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Study shows highest risk of vitamin D deficiency in BAME babies

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

The effect of vaccination on the spread of COVID-19 disease

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

New polio vaccine is the first to work on mutated form of the virus

$20.6 billion to restore crumbling services for women, newborns, children and adolescents

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

UCI researchers develop new technology to rapidly hypermutate antibodies

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Researchers urge policymakers to prioritize people with diabetes for COVID-19 vaccination

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

Come for your eye exam, leave with a band-aid on your arm

Feds look to pharmacists to boost childhood immunization rates

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News